Abstract:Background: γ-Glutamylcyclotransferase (GGCT), an enzyme crucial in glutathione metabolism, has emerged as a participant in tumorigenesis. The present study is designed to elucidate the biological role and molecular mechanisms underlying GGCT in glioma. Methods: Gene Expression Profiling Interactive Analysis (GEPIA), Chinese Glioma Genome Atlas (CGGA), and PrognoScan online databases were utilized to examine the expressions and clinical prognosis of GGCT and REST in glioma. Cell Counting Kit-8 (CCK-8), Transwell, Wound healing, and Flow cytometric assays, and RNA-sequencing analysis were employed to uncover the molecular role of GGCT and REST. Prediction of Differentially expressed microRNA (DE-miRNAs) and miRNAs targeting GGCT 3' Untranslated Region (UTR) was performed using miRanda online datasets. Finally, Real time-quantitative Polymerase Chain Reaction (RT-qPCR), western blot and dual luciferase reporter gene activity analysis were employed to confirm a positive feedback loop involving GGCT/REST/miR-34a-5p in glioma cells. Results: High expression of GGCT was correlated with poor prognosis in glioma. GGCT silencing demonstrated inhibitory effects on the proliferation, migration, and induction of apoptosis in T98G and U251 cells. Mechanistically, GGCT downregulated REST expression and modulated cancer-associated pathways in glioma cells. High expression of REST was associated with poor prognosis in glioma. In vitro and in vivo experiments showed that REST overexpression restored the repression of proliferation, invasion, migration, and xenograft tumor formation induced by GGCT knockdown. Furthermore, the study uncovered that REST inhibited miR-34a-5p mRNA expression, and miR-34a-5p suppressed GGCT expression by targeting its 3'UTR, forming a positive regulatory loop in glioma. Notably, the inhibitor of miR-34a-5p restored the role of REST silencing in decreasing GGCT expression in glioma cells. Conclusions: GGCT/REST/miR-34a-5p axis holds promising potential as a therapeutic target, offering a potential breakthrough in the treatment of glioma.

Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy

Tumor and Serum Gamma-Glutamyl Transpeptidase, New Prognostic and Molecular Interpretation of an Old Biomarker in Gastric Cancer

Knockdown of GGCT Inhibits Cell Proliferation and Induces Late Apoptosis in Human Gastric Cancer

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

Desert Hedgehog Down-regulation Mediates Inhibition of Proliferation by γ-Glutamylcyclotransferase Knockdown in Murine Glioblastoma Stem Cells

Catabolism of extracellular glutathione supplies amino acids to support tumor growth

Glutamine Synthetase as a Therapeutic Target for Cancer Treatment

γ-Glutamylcyclotransferase is transcriptionally regulated by c-Jun and controls proliferation of glioblastoma stem cells through Notch1 levels

Glutaminase - A potential target for cancer treatment

Advance in Antitumor Agents Targeting Glutathione-S-transferase.

Γ-Glutamyl Cyclotransferase Contributes to Tumor Progression in High Grade Serous Ovarian Cancer by Regulating Epithelial-Mesenchymal Transition Via Activating PI3K/AKT/mTOR Pathway.

Gamma-glutamylcyclotransferase Promotes the Growth of Human Glioma Cells by Activating Notch-Akt Signaling.

Abstract 449: Catabolism of GSH by GGT supports cancer cell survival

Identified γ-glutamyl cyclotransferase (GGCT) as a novel regulator in the progression and immunotherapy of pancreatic ductal adenocarcinoma through multi-omics analysis and experiments

Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy

Regulation and Clinical Significance of O-GlcNAc Transferase in Cancer

Targeting GLS1 to cancer therapy through glutamine metabolism

Targeting glutamine metabolism as a therapeutic strategy for cancer

The GGCT and REST positive feedback loop promotes tumor growth in Glioma

The roles of OGT and its mechanisms in cancer

Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies